日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dapagliflozin improves diabetic cardiomyopathy by suppressing the STAT3-YY1 signaling axis in cardiac fibroblasts

达格列净通过抑制心脏成纤维细胞中的STAT3-YY1信号通路改善糖尿病心肌病

Shen, Xing-Yi; Li, Xi-Ya; Hu, Zuo-Ying; Xie, Hao

LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates diabetic cardiomyopathy by inhibiting inflammation, oxidative stress and apoptosis.

LCZ696 是一种血管紧张素受体-脑啡肽酶抑制剂,它通过抑制炎症、氧化应激和细胞凋亡来改善糖尿病心肌病

Ge Qing, Zhao Li, Ren Xiao-Min, Ye Peng, Hu Zuo-Ying

Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system

肺动脉去神经支配术通过调节局部肾素-血管紧张素-醛固酮系统改善肺动脉高压引起的右心室功能障碍。

Liu, Chen; Jiang, Xiao-Min; Zhang, Juan; Li, Bing; Li, Jing; Xie, Du-Jiang; Hu, Zuo-Ying

I(f) current channel inhibitor (ivabradine) deserves cardioprotective effect via down-regulating the expression of matrix metalloproteinase (MMP)-2 and attenuating apoptosis in diabetic mice

I(f)电流通道抑制剂(伊伐布雷定)可通过下调基质金属蛋白酶(MMP)-2的表达和减轻糖尿病小鼠的细胞凋亡,发挥心脏保护作用。

Chen, Shao-Liang; Hu, Zuo-Ying; Zuo, Guang-Feng; Li, Ming-Hui; Li, Bin